Quality Systems

• Don't Let Negative Interest Rates Scare you Away

  By Joshua Bondy - May 14, 2013 | Tickers: CALM, CPSI, PAYX, QSII, SPY

  With real U.S. short term interest rates around -1.25%, a recent study found that the stock market's real five year returns should be around 3.6%. A real return of 3.6% is is less than what many people and pension funds expect, but at least it is a positive figure. By investing in quality companies with strong yields, you can remove a large amount of stress more »

• On Health IT, Fools Go With the Hot Hand

  By Dana Blankenhorn - February 28, 2013 | Tickers: MDRX, CERN, MCK, MDSO, QSII |

  Last time we checked in on the health IT sector, it was on fire.

  Some $19.2 billion in federal stimulus dollars were headed the sector's way, to be doled out based on completion of “meaningful use” requirements then being written by a committee of government and industry bureaucrats.

  But writing and meeting requirements is one thing. Delivering value is something else. This has suddenly dawned on the industry more »

• Profitable Companies With High Insider Ownership (Last Part)

  By Anh HOANG - January 14, 2013 | Tickers: INFY, QSII, SYNT

  In the previous article, I wrote about two profitable companies that have high insider ownership. One was Oracle, the global leader in both hardware and software for enterprise solutions. The other was Papa John’s, the pizza chain operator with more than 4,000 restaurants. In this article, I would like to highlight two more stocks that fit the screening criteria: (1) market capitalization higher than $1 billion, (2) the more »

• A Healthcare Hedge Fund Is Really Bullish About This Stock

  By Meena Krishnamsetty - December 28, 2012 | Tickers: MDRX, ATHN, CERN, MCK, QSII

  At the end of September, Healthcor Management’s largest 13F position by market value was its 14 million shares of Allscripts Healthcare Solutions (NASDAQ: MDRX) (check out more of their stock picks). Since then, the fund- which invests the majority of its capital in healthcare- has increased its stake to close to 16 million shares, giving it 9.3% of the outstanding shares of the provider of healthcare software and more »

• Insiders Here Don’t Think a Takeover is Necessary

  By Meena Krishnamsetty - August 6, 2012 | Tickers: MDRX, ATHN, MCK, QSII

  Quality Systems Inc. (NASDAQ: QSII), which provides clinical software for healthcare clients such as dentists and hospitals, saw three large insider transactions reported on July 31^st. George Bristol, a member of the Board of Directors, bought 10,000 shares of the stock at an average price of $16.02. Insider buying is generally considered a bullish sign because insiders have an incentive to diversify their portfolios and cash flows more »

• Quality Systems Inc - A Total Return Story on Sale

  By Chuck Carnevale - June 6, 2012 | Tickers: QSII

  When I’m looking for growth, I screen for companies with historical track records of earnings growth of 15% to 20% or better. In truth and practicality, companies capable of generating that kind of growth are very rare. Moreover, to find one with an attractive and growing dividend yield is rarer still. Yet, there is one company that meets all the qualities I’ve discussed thus far, and best of all, I believe it is currently on sale.  The company is Quality Systems Inc. (NASDAQ: QSII), a leader in offering electronic health records to medical practices and hospitals throughout the United States.

• When Will it Be Safe to Buy Allscripts?

  By Keith Speights - April 30, 2012 | Tickers: MDRX, ATHN, CERN, CPSI, MCK, QSII |

  Triple Whammy
  Allscripts (NASDAQ: MDRX) experienced a triple whammy last week. First, there was upheaval in their board with the chairman ousted and three directors apparently resigning in protest. Second, the company announced that its CFO was departing to go to another company outside of the healthcare industry. Third, Allscripts revealed that its earnings for the previous quarter were half of what was expected. It’s no wonder that the more »

• Is This Stock Overvalued?

  By Christopher French - January 26, 2012 | Tickers: MDRX, CERN, QSII

  Cerner (NASDAQ: CERN) has been a popular name in the stock market with the federal government’s drive to modernize health records. Its stock, however, hasn’t been doing well recently as it appears to be overvalued at these levels.

  Cerner’s trailing 5 year valuation metrics suggest that the stock is overvalued, in my opinion. Cerner’s current P/B ratio is 4.6 and it has averaged 3 more »

• J.P. Morgan Healthcare Conference Schedule: Day One

  By Brandy Betz - January 8, 2012 | Tickers: ARAY, ACOR, A, ALGN, AMRN, AMGN, AMLN, ARTC, BIIB, BMRN, BRKR, CFN, CTRX, CELG, CNC, COV, DNDN, XRAY, EW, ENDP, EPOC, ESRX, GHDX, GILD, HLS, HTWR, HMSY, HGSI, IDXX, IPXL, INCY, IRWD, MCK, MRX, MDT, MR, MOH, MYL, NVS, ONXX, PRX, PRGO, QSII, REGN, RMD, RIGL, SGEN, ST, SIAL, THC, MDCO, THOR, VRTX, VVUS, WAT, WMGI, ZLTQ

  The 30th Annual J.P. Morgan Healthcare Conference kicks off with a full day of presentations from companies that range from global pharmaceutical leaders to small cap novel pharmaceutical developers and health technology manufacturers. The majority of the presentations will be available through live webcasts with archived replay offered later in the day.

  I will be following (and covering) the novel therapeutic companies that have caught my eye. VIVUS (NASDAQ: VVUSmore »)